18 and older, any sex, with Multiple Sclerosis or Pain. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Participant Perception of Me Time MS App UsabilityPrimary· Up to 2 weeks after the 6-week app usage period ended
Qualitative descriptions of positive, negative, and neutral aspects of usability of the Me Time MS app, gathered through one-on-one, open-ended interviews after 6 weeks of access to the app. Results reflect the total number of comments across all participants that were provided for each category. Participants could submit multiple types of comments.
Positive
Group
Value
95% CI
Relaxing Self-Acupressure
37
Stimulating Self-Acupressure
11
Negative
Group
Value
95% CI
Relaxing Self-Acupressure
9
Stimulating Self-Acupressure
4
Neutral
Group
Value
95% CI
Relaxing Self-Acupressure
13
Stimulating Self-Acupressure
6
System Usability Scale (SUS) Adapted for the MeTime MS AppSecondary· Up to 2 weeks after the 6-week app usage period ended
SUS is a custom, 10-item survey to assess the participant's perception of the usability of the MeTime MS app. Possible total score ranges from 0 (lowest usability) to 40 (highest usability).
Group
Value
95% CI
Relaxing Self-Acupressure
35.8
± 2.28
Stimulating Self-Acupressure
29.5
± 6.36
Adverse events — posted to ClinicalTrials.gov
Time frame: Up to 8 weeks.
Reporting threshold: 0%.
Adverse-event reports describe events observed during the trial — not all are caused by the drug.
Relaxing Self-Acupressure
Serious: 0/5 (0%)
Deaths: 0/5
Stimulating Self-Acupressure
Serious: 0/5 (0%)
Deaths: 0/5
Other adverse events (4 terms — click to expand)
Reaction
System
Relaxing Self-Acupressure
Stimulating Self-Acupressure
Soreness
General disorders
—
—
Fatigue
General disorders
—
—
Cramping
Nervous system disorders
—
—
Difficulty with certain acupoints due to limited mobility
The Me Time MS Application was designed to enable self-administration of acupressure. Two forms of acupressure - either "relaxing" or "stimulating" protocols - are administered through the Me Time MS app.
The goal of this study is to assess the usability of the Me Time MS app in a sample of 10 adults with multiple sclerosis (MS).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
NCT07507084 — The Effect of Internal- or External-Focused Exercise Training, Administered in Conjunction With a Cognitive Task, on Wal
· NA
· recruiting
NCT07524231 — Evaluation of the Effects of Laughter Yoga
· NA
· recruiting
NCT07489794 — URINARY INCONTINENCE AND PELVIC FLOOR MUSCLE ACTIVITY IN MULTIPLE SCLEROSIS
· recruiting
NCT07236684 — Identification of Factors Related to UI in Patients With MS and EMG Assessment of PFM Activity
· recruiting
NCT07500727 — Skeletal Muscle Aging and Responsiveness in Aged People With MS
· NA
· recruiting
Other University of Michigan trials
Trials by the same sponsor.
NCT07536919 — Integrating Care for Hypertension-Diabetes MULTImorbidity in Guatemala Through HEARTS Implementation
· NA
· not yet recruiting
NCT05509842 — Function-based Accelerated Stimulation Therapy (FAST-therapy) for Freezing of Gait (FOG) After Parkinson's Disease (PD)
· NA
· not yet recruiting
NCT06311188 — Exploring PTSD Symptoms, Barriers and Facilitators to Mindfulness
· NA
· not yet recruiting
NCT07471646 — Effects of Ramadan Fasting With Exercise on Cardiometabolic Health
· NA
· not yet recruiting
NCT06671925 — A Community Health Worker-Led Program for Chronic Pain and Loneliness in Older Adults
· NA
· recruiting
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Michigan
Last refreshed: 20 November 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07123272.